Here’s what you need to know about Pfizer’s COVID-19 vaccine
US drug manufacturer Pfizer, in partnership with German medical research company BioNTech, today announced its ongoing COVID-19 vaccine trials had reached a significant milestone in the form of a preliminary efficacy rate of 90%. This is good news, but based on what we know so far it’s far too early to start celebrating. Here’s what you need
Read More